PCI Pharma Services Capabilities Update May 2026: Combination Products & Drug Delivery

In this presentation, Justin Schroeder, Vice President of Global Technical Services, will provide an overview of PCI’s integrated global capabilities for injectable drug products and drug-device combination products. He specifically discusses how PCI supports customers throughout the product lifecycle—from clinical development through commercial launch—with scalable solutions for final assembly, packaging, labeling, and testing.

Viewers will gain insight into PCI’s global network, manufacturing capacities, and device-agnostic approach to supporting a wide range of injectable delivery systems. Justin will also highlight the company's strategic investments in advanced technologies, automation, and facility expansions designed to address the increasing demand for flexible, scalable, and reliable drug-device combination product services. The session also explores how these investments enable PCI to help pharmaceutical and biotechnology companies accelerate development timelines, mitigate supply chain risks, and successfully transition products from clinical supply to commercial-scale production.